HFE alleles in an Irish cystic fibrosis population

Genetic Testing

Volumn 7, Issue 2, 2003, Pages 155-158

  Devaney, James ^a,b   Maher, M ^a   Smith, T ^a   Houghton, J A ^a   Glennon, M ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

HFE PROTEIN;

ALLELE; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE CARRIER; DNA MODIFICATION; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC SCREENING; HETEROZYGOTE; HUMAN; IRELAND; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MECONIUM ILEUS; POLYMERASE CHAIN REACTION;

ALLELES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA MUTATIONAL ANALYSIS; GENE FREQUENCY; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMOZYGOTE; HUMANS; ILEUS; IRELAND; LIVER DISEASES; MEMBRANE PROTEINS; PHENOTYPE;

EID: 0037477694     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/109065703322146876     Document Type: Article

References (26)

1. BEUTLER, E., GELBART, T., WEST, C., LEE, P., ADAMS, M., BLACKSTONE, R., POCKROS, P., KOSTY, M., VENDITTI, C.P., PHATAK, P.D., et al. (1996). Mutation analysis in hereditary hemochromatosis. Blood. Cells. Mol. Dis. 22, 187-194.
2. BRADLEY, L.A., JOHNSON, D.D., PALOMAKI, G.E., HADDOW, J.E., ROBERTSON, N.H., and FERRIE, R.M. (1998). Hereditary haemochromatosis mutation frequencies in the general population. J. Med. Screen. 5, 34-36.
3. CASTALDO, G., FUCCIO, A., SALVATORE, D., RAIA, V.V., SANTOSTASI, T., LEONARDI, S., LIZZI, N., ROSA, M.L., RIGILLO, N., and SALVATORE, F. (2001). Liver expression in cystic fibrosis could be modulated by genetic factors different from the cystic fibrosis transmembrane regulator genotype. Am. J. Med. Genet. 98, 294-297.
4. COLOMBO, C., APOSTOLO, M.G., FERRARI, M., SEIA, M., GENONI, S., GIUNTA, A., and SERENI, L.P. (1994). Analysis of risk factors for the development of liver disease associated with cystic fibrosis. J. Pediatr. 124, 393-394.
5. DEAN, M., SCHMURA, S., OSBORNE, L., COREY, M., CARRINGTON, M., PARAD, R., PIER, G., KNOWLES, M., and KNIGHT, R. (1995). Association of the HLA DQA gene with pulmonary disease severity - A multicohort study. Pediatr. Pulmonol. s12, 206.
6. FAKHOURY, K., DURIE, P.R., LEVISON, H., and CANNY, G.J. (1992). Meconium ileus in the absence of cystic fibrosis. Arch. Dis. Child. 67, 1204-1206.
7. FEDER, J.N., GNIRKE, A., THOMAS, W., TSUCHIHASHI, Z., RUDDY, D.A., BASAVA, A., DORMISHIAN, F., DOMINGO, R., JR., ELLIS, M.C., FULLAN, A., et al. (1996). A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genet. 13, 399-408.
8. FEINGOLD, J., and GUILLOUD-BATAILLE, M. (1999). Genetic comparisons of patients with cystic fibrosis with or without meconium ileus. Clinical Centers of the French CF Registry. Ann. Genet. 42, 147-150.
9. JEFFREY, G.P., CHAKRABARTI, S., HEGELE, R.A., and ADAMS, P.C. (1999). Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis. Nature Genet. 22, 325-326.
10. JOUANOLLE, A.M., GANDON, G., JEZEQUEL, P., BLAYAU, M., CAMPION, M.L., YAOUANQ, J., MOSSER, J., FERGELOT, P., CHAUVEL, B., BOURIC, P., et al. (1996). Haemochromatosis and HLA-H. Nature Genet. 14, 251-252.
11. KEREM, B.S., ROMMENS, J.M., BUCHANAN, J.A., MARKIEWICZ, D., COX, T.K., CHAKRAVARTI, A., BUCHWALD, M., and TSUI, L.C. (1989a). Identification of the cystic fibrosis gene: genetic analysis. Science 245, 1073-1080.
12. KEREM, B.S., BUCHANAN, J.A., DURIE, P., COREY, M.L., LEVISON, H., ROMMENS, J.M., BUCHWALD, M., and TSUI, L.C. (1989b). DNA marker haplotype association with pancreatic sufficiency in cystic fibrosis. Am. J. Hum. Genet. 44, 827-834.
13. KRISTIDIS, P., BOZON, D., COREY, M., MARKIEWICZ, D., ROMMENS, J., TSUI, L.C., and DURIE, P. (1992). Genetic determination of exocrine pancreatic function in cystic fibrosis. Am. J. Hum. Genet. 50, 1178-1184.
14. LUCOTTE, G. (1998). Celtic origin of the C282Y mutation of hemochromatosis. Blood. Cells. Mol. Dis. 24, 433-438.
15. MERRYWEATHER-CLARKE, A.T., POINTON, J.J., SHEARMAN, J.D., and ROBSON, K.J. (1997). Global prevalence of putative haemochromatosis mutations. J. Med. Genet. 34, 275-278.
16. MORRAL, N., BERTRANPETIT, J., ESTIVILL, X., NUNES, V., CASALS, T., GIMENEZ, J., REIS, A., VARON-MATEEVA, R., MACEK, M., JR., and KALAYDJIEVA, L. (1994). The origin of the major cystic fibrosis mutation (delta F508) in European populations. Nature Genet. 7, 169-175.
17. NOUSIA-ARVANITAKIS, S., FOTOULAKI, M., ECONOMOU, H., XEFTERI, M., and GALLI-TSINOPOULOU, A. (2001). Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease. J. Clin. Gastroenterol. 32, 324-328.
18. ROHLFS, E.M., SHAHEEN, N.J., and SILVERMAN, L.M. (1998). Is the hemochromatosis gene a modifier locus for cystic fibrosis? Genet. Test. 2, 85-88.
19. ROZMAHEL, R., WILSCHANSKI, M., MATIN, A., PLYTE, S., OLIVER, M., AUERBACH, W., MOORE, A., FORSTNER, J., DURIE, P., NADEAU, J., et al. (1996). Modulation of disease severity in cystic fibrosis transmembrane conductance regulator (CFTR) deficient mice by a secondary genetic factor. Nature Genet. 12, 280-287.
20. RYAN, F., and VAUGHAN, J. (2000). Haemochromatosis mutation analysis in a normal Irish population. Biomed. Sci. Brief. 57, 315.
21. RYAN, E., O'KEANE, C., and CROWE, J. (1998). Hemochromatosis in Ireland and HFE. Blood Cells Mol. Dis. 24, 428-432.
22. SCHWARZ, M.J., MALONE, G.M., HAWORTH, A., CHEADLE, J.P., MEREDITH, A.L., GARDNER, A., SAWYER, I.H., CONNARTY, M., DENNIS, N., SELLER, A., et al. (1995). Cystic fibrosis mutation analysis: report from 22 U.K. regional genetics laboratories. Hum. Mutat. 6, 326-333.
23. SCOTT-JUPP, R., LAMA, M., and TANNER, M.S. (1991). Prevalence of liver disease in cystic fibrosis. Arch. Dis. Child. 66, 698-701.
24. SIMON, M., LE MIGNON, L., FAUCHET, R., YAOUANQ, J., DAVID, V., EDAN, G., and BOUREL, M. (1987). A study of 609 HLA haplotypes marking for the hemochromatosis gene: (1) mapping of the gene near the HLA-A locus and characters required to define a heterozygous population and (2) hypothesis concerning the underlying cause of hemochromatosis-HLA association. Am. J. Hum. Genet. 41, 89-105.
25. WELSH, M.J., TSUI, L.C., BOST, T.F., and BEAUDET, A.L. (1995). Cystic fibrosis. In The Metabolic and Molecular Basis of Inherited Disease, 7th ed., C.R. Scrivener, A.Z. Beaudet, W.S. Sly et al. (eds.). McGraw-Hill, New York, pp. 3799-3879.
26. ZIELENSKI, J., COREY, M., ROZMAHEL, R., MARKIEWICZ, D., AZNAREZ, I., CASALS, T., LARRIBA, S., MERCIER, B., CUTTING, G.R., KREBSOVA, A., et al. (1999). Detection of a cystic fibrosis modifier locus for meconium ileus on Human chromosome 19q13. Nature Genet. 22, 128-129.